KADIAN
KADIAN
Approved
DIN Number
02184451
Drug Class
Human
Market Date
Oct 25, 1996
Company
HC
BGP Pharma ULC
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02184451
AIG Number0104545012
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA I)
A
ATC Code
N02AA01 MORPHINE
Product Specifications
Dosage FormCapsule (Sustained-Release)
Route of AdministrationOral
AHFS Classification28:08.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
MORPHINE SULFATEActive
Strength: 100 MG
Monograph: MORPHINE SULFATE